Molecular pharmaceutics
Preclinical Study of CDH3-Targeted 89Zr/177Lu Theranostics in Triple-Negative Breast Cancer.
Mingming Tang, Huayan Zhang, Huan Du, Xiaofei Hao, Binwei Lin, Yihan Zhu, Decai Wang, Wei Wu, Xiaobo Du
Published: 202610.1021/acs.molpharmaceut.5c01584
Abstract
Triple-negative breast cancer (TNBC) is characterized by poor prognosis, limited therapeutic options, and low survival rates, underscoring the urgent need for novel and effective treatment strategies. This study aimed to investigate the potential of…
Preview only. Read the full abstract at the source